Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
127
days
Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition
Authors
Erik Moedt; Akihiko Koshino; Niels Jongs; Wenjun Ju; Viji Nair; Matthias Kretzler; Michael K. Hansen; Clare G. Arnott; David C. Wheeler; Peter Rossing; Steven G. Coca; Ann Hammarstedt; Peter J. Greasley; Petter Bjornstad; Stephan J.L. Bakker; Hiddo J.L. HeerspinkShow moreShow less
Affiliations
1. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 2. Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan; 3. Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 4. Janssen Research and Development, LLC, Spring House, Pennsylvania; 5. The George Institute for Global Health, Sydney, New South Wales, Australia; 6. Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; 7. Department of Renal Medicine, University College London, London, United Kingdom; 8. Steno Diabetes Center Copenhagen, Herlev, Denmark; 9. Icahn School of Medicine at Mount Sinai, New York, New York; 10. Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 11. Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 12. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; 13. Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsShow moreShow less
91
days
B-Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor-T–Cell Therapy for Relapsed or Refractory AL Amyloidosis
Authors
Xianghua Huang; Xiaomei Wu; Wencui Chen; Wenshi Wang; Weiwei Xu; Jinzhou Guo; Jinghua Zhao; Xiaodong Xu; Chris Wang; Aidong Shan; Jiawei Xu; Zhihong LiuShow moreShow less
Affiliations
1. National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; 2. Shanghai Fosun Kairos Biotechnology Co., Ltd., Shanghai, ChinaShow moreShow less
148
days
Kidney Function and Blood and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Related Dementias
Authors
Yuwei Lin; Zaixin Zhao; Nanbo Zhu; Sara Garcia Ptacek; Juan-Jesus Carrero; Annette Bruchfeld; Maria Eriksdotter; Michelle M. Mielke; Nele Brusselaers; Hong XuShow moreShow less
Affiliations
1. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; 2. Institute of Advanced Clinical Medicine, Peking University, Beijing, China; 3. Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden; 4. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 5. Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden; 6. Department of Nephrology and Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 7. Department of Renal Medicine, Karolinska University Hospital, CLINTEC Karolinska Institutet, Stockholm, Sweden; 8. Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 9. Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; 10. Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Antwerp, Belgium; 11. Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumShow moreShow less
120
days
Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis
Authors
Benjamin Lidgard; Andrew N. Hoofnagle; Leila R. Zelnick; Ian H. de Boer; Paul Jensen; Amanda M. Fretts; David S. Siscovick; Jason G. Umans; Nisha Bansal; Rozenn N. LemaitreShow moreShow less
Affiliations
1. Department of Medicine, University of Washington, Seattle, Washington; 2. New York Academy of Medicine, New York, New York; 3. Department of Medicine, Georgetown University, Washington, DCShow moreShow less
145
days
Inhibition of IL-33 in Diabetic Kidney Disease
Authors
Alexis Hofherr; Kaisa Mäki-Petäjä; Viknesh Selvarajah; Daniel Grice; Stefano Bartesaghi; Eulalia Jimenez; Roberto Pecoits-Filho; Hiddo J.L. HeerspinkShow moreShow less
Affiliations
1. Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 2. Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom; 3. Biometrics, Cardiovascular, Renal and Metabolism, Data Science and Artificial Intelligence, R&D, AstraZeneca, Gaithersburg, Maryland; 4. Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 5. Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain; 6. Arbor Research Collaborative for Health, Ann Arbor, Michigan; 7. School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil; 8. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 9. The George Institute for Global Health, University of New South Wales Sydney, Barangaroo, New South Wales, AustraliaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days